NMO Spectrum Disorder: Clinical Trials

5 trials for NMO Spectrum Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 recruiting. 5 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Active not recruiting 1, Recruiting 1
Phase 22Completed 1, Recruiting 1

Follow NMO Spectrum Disorder: new trials by email Literature Review of NMO Spectrum Disorder trials Research Report on NMO Spectrum Disorder

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
BAFF-R CART - Chronic Inflammatory Demyelinating Polyradiculoneuropathy, NMO Spectrum Disorder
Phase 1 / Phase 2RecruitingTianjin Medical University General Hospital272025-04-102026-10-16
Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders
Baricitinib - NMO Spectrum Disorder
Phase 1Active not recruitingTianjin Medical University General Hospital112023-04-152026-08-11
A Study of LP-168 in Healthy Volunteers
LP-168 tablet, LP-168 Placebo tablet - Multiple Sclerosis, NMO Spectrum Disorder
Phase 1CompletedGuangzhou Lupeng Pharmaceutical Company LTD.702022-05-142023-02-24
Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders
Belimumab - NMO Spectrum Disorder
Phase 1 / Phase 2CompletedTianjin Medical University General Hospital142021-12-122024-10-16
A Study of HBM9161 in NMOSD Patients
HBM9161 Injection - NMO Spectrum Disorder
Phase 1CompletedHarbour BioMed (Guangzhou) Co. Ltd.92020-03-312022-01-25

Narrower conditions

Neuromyelitis Optica (5)  ·  Multiple Sclerosis (1)  ·  Myasthenia Gravis (1)  ·  Myositis (1)  ·  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)

Broader conditions

Autoimmune Diseases (5)  ·  Autoimmune Diseases of the Nervous System (5)  ·  Cranial Nerve Diseases (5)  ·  Demyelinating Autoimmune Diseases, CNS (5)  ·  Demyelinating Diseases (5)  ·  Eye Diseases (5)  ·  Immune System Diseases (5)  ·  Myelitis, Transverse (5)  ·  Nervous System Diseases (5)  ·  Optic Nerve Diseases (5)  ·  Optic Neuritis (5)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)

Interventions

HBM9161 (1)  ·  baricitinib (1)  ·  belimumab (1)

Sponsors

Tianjin Medical University General Hospital (3)  ·  Guangzhou Lupeng Pharmaceutical Company LTD. (1)  ·  Harbour BioMed (Guangzhou) Co. Ltd. (1)

Countries

China (5)

Top investigators

Jinliang Chen, PhD (1)  ·  Qiang Liu, M.D.,Ph.D (1)  ·  Qiang Liu, M.D.,PhD (1)  ·  Wei Qiu (1)

Results publications

PMID 40489809